Sophie McGrath

Described by Chambers as “a superb corporate lawyer,” Sophie McGrath is a partner in Goodwin’s Life Sciences, Healthcare and Technology groups. Sophie has over 20 years’ experience focusing on transactions in the life sciences, healthcare and technology sectors, acting for companies at all stages of development, as well as investors and management teams. She advises on a wide range of corporate matters, including private and public financings, mergers and acquisitions, public offerings, and restructurings.

As the Co-Chair of Goodwin’s European Healthcare initiative, Sophie plays a pivotal role in shaping the firm’s strategic initiatives in this sector. Sophie collaborates with Goodwin attorneys across multiple disciplines such as corporate, commercial, intellectual property, private equity and regulatory to ensure that the firm’s European Healthcare clients are receiving cutting edge legal advice on the distinct challenges and opportunities within the European healthcare sector. With a sharp focus on emerging legal trends, Sophie has a particular interest in the growth of private equity investments within the Life Sciences and Healthcare sectors and works closely with her colleagues in the Private Equity team to provide clients with invaluable insights and strategic legal counsel on these transactions.

Sophie is one of the leaders of Goodwin’s Women’s Health and Wellness Initiative and is heavily involved in supporting entrepreneurs, companies and investors dedicated to advancing innovation in the field of women’s health and wellness. Sophie is also passionate about promoting and supporting women in the Life Sciences, Healthcare and Technology sectors, representing an impressive portfolio of women led companies such as Micrographia, Dunad, Aavantgarde and Jeito, the first women led life sciences focused venture capital fund. Sophie leads various initiatives and events at Goodwin focusing on women, including its annual Women in Life Sciences networking event and its Female Founders Dinner.